3-(Morpholine-4-carbonyl)benzonitrile, 98%, 500mg

7-BROMO-5-NITRO-1H-INDAZOLE, 95%, 1g

Éter monopropílico de propilenglicol, mín. 99 %, para síntesis, 5 l, envase de plástico.

N-(4-Methoxybenzylidene)-4-butylaniline>98.0%(GC)(T)25g

4-((1-(Tert-butoxycarbonyl)piperidin-4-yl)oxy)benzoic acid, 95+%, 100mg

H-D-Leu-OBzl.TosOH, 98%, 100g

4-[[4-[(4,6-Dimethylpyrimidin-2-yl)oxy]phenyl]amino]-4-oxo-(2Z)-butenoic acid, 1g

2-(2,4-Difluorobenzoyl)-6-methoxypyridine, 97.0%, 1g

1-Methyl-3-thien-2-yl-1H-pyrazole-5-carboxylic acid, 95.0%, 2.5g

2-[2-(2-Azidoethoxy)ethoxy]ethanol, 98.0%, 25g

(S)-3-(tert-Butoxycarbonylamino)-2-[(9H-fluoren-9-ylmethoxy)carbonylamino]propionic Acid>97.0%(T)(HPLC)1g

3-Chloro-2-fluoroaniline, 99.00%, 100g

1-(4-(Benzyloxy)-2-hydroxy-6-methoxyphenyl)ethanone, 98%, 100mg